Neihulizumab
Showing 1 - 4 of 4
Steroid-refractory Acute Graft-versus-Host Disease, Treatment-refractory Acute Graft-versus-Host Disease Trial in United States
Completed
- Steroid-refractory Acute Graft-versus-Host Disease
- Treatment-refractory Acute Graft-versus-Host Disease
- Neihulizumab (ALTB-168)
-
Duarte, California
- +12 more
Jan 17, 2023
Ulcerative Colitis Trial in Puerto Rico, United States (AbGn-168H)
Completed
- Ulcerative Colitis
- AbGn-168H
-
Little Rock, Arkansas
- +11 more
Aug 13, 2020
Acute GVHD Trial in Stanford (AbGn-168H)
Terminated
- Acute Graft Versus Host Disease
- AbGn-168H
-
Stanford, CaliforniaStanford University, School of Medicine
Mar 28, 2017
Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation Trial in Houston, Seattle (Neihulizumab
Withdrawn
- Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
- Neihulizumab Treatment
- Conventional Treatment
-
Houston, Texas
- +1 more
Apr 22, 2016